Compliant treatment with anti‐copper agents prevents clinically overt <scp>W</scp>ilson's disease in pre‐symptomatic patients

Abstract

The use of anti-copper agents in clinically pre-symptomatic patients diagnosed with WD allows clinically overt disease to be effectively prevented. However, compliance with therapy is extremely important.